Abstract:
The invention relates to new tissue-specific calpaines and their production. The invention also relates to a method for screening for new calpaine inhibitors and their use.
Abstract:
The invention relates to calpain protease 12 (Capn12), which is characterized in that it has an amino acid sequence comprising amino acids 1 - 342 of SEQ ID NO: 1 or an amino acid sequence selected amongst SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3 or SEQ ID NO: 4. The invention also relates to the functional analogs of said calpain protease 12, to the nucleic acids coding therefor, to recombinant vectors containing said coding sequences and to microorganisms transfected therewith. The invention further relates to a method for recombinant production of Capn12 and to different applications of Capn12 and the nucleic acids coding therefor.
Abstract translation:钙蛋白酶蛋白酶12(Capn12),其特征在于,一个氨基酸序列,其包含氨基酸SEQ ID NO 1-342:1或SEQ ID NO的氨基酸序列:1,SEQ ID NO:2,SEQ ID NO:3 或SEQ ID NO:4; 以及它们的功能类似物; 对于这种编码核酸; 含有这些编码序列的重组载体; 转染的微生物; 重组生产Capn12的方法; 以及Capn12和编码它的核酸的各种应用。
Abstract:
The invention relates to new tissue-specific calpaines and their production. The invention also relates to a method for screening for new calpaine inhibitors and their use.
Abstract:
The invention relates to new tissue-specific calpaines and their production. The invention also relates to a method for screening for new calpaine inhibitors and their use.
Abstract:
The invention relates to novel calpaines and their production. The invention further relates to a screening method for new calpaine inhibitors and the use thereof.
Abstract:
The invention relates to new tissue-specific calpaines and their production. The invention also relates to a method for screening for new calpaine inhibitors and their use.